Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results
Leveraging RNA Seq for a robust accurate measure

Presentation from The 2017 Immuno-Oncology Summit In Boston, MA

What can LC-MS offer beyond LBA approaches in the field of large molecule?

Liquid Chromatography-Mass Spectrometry offers many advantages in protein bioanalysis

Optimization of High-Resolution MS Parameters for an Automated...

Presented at the 65th ASMS Conference on Mass Spectrometry and Allied Topics

Copy number detection using Viterbi (Covit)

Presentation from Cancer Genomics Consortium, August 2017

Just When You Thought You Knew Bioanalysis - Protein Bioanalysis by LC-MS

The importance of LC-MS in advancing protein bioanalysis

Minimal Residual Disease Finding the Right Test for the New Definition of...

Measurement of Residual Disease for improved oncology trial outcomes

NGS methods capturing splice variants: Picking the right tool to detect...

Presentation from Precision: Lung Cancer Summit, July 2017

Fighting Cancer Biomarkers for Immuno-Oncology Clinical Trials

Using anatomic pathology for biomarker development in clinical trials can help predict and assess...

Technical Innovations Advance Gene Expression Profiling

Small-Volume RNA-seq and Improved SMART-Seq® v4 Workflow

Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials

Genomic technologies that empower and enhance immuno-oncology trials

The End to End Importance of Selecting the Right Biomarker in Cancer...

A critical component in the fight against cancer and optimizing treatment outcomes for patients

Best Practices for Integrating Biomarkers across the Drug Development...

A roadmap for a successful biomarker strategy